TRENDING :  Market Movers  |  Top 50   SPY (0.23%)    TSLA (-2.49%)    CANF (1.36%)    BYND (-2.96%)    BTCUSD (%)    ONCS (-3.12%)    AMZN (0.43%)    TVIX (-4.25%)    VXX (-2.07%)    ROKU (6.45%)    ACAD (2.45%)    OIH (-1.43%)    MCHP (-1.44%)    MAXR (-13.79%)    IRBT (0.03%)    IP (-0.24%)    INTC (0.09%)    GDX (0.64%)    FTNT (0.33%)    ECOR (-4.53%)    DNR (3.23%)    DIS (0.05%)    DFRG (2.06%)    CMG (-0.69%)    BIOC (9.74%)

 PIRS - Pieris Pharmaceuticals

$4.41 [0.67][17.61%]

Next Earnings

8/8/2019

BMO

Recommend
Trade Idea »



ANALYST RATINGS

Quarterly Rating Chart
Rating

1


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $5.00
Low $5.00
Average $5.00
Current $4.41

CompanyAnalyst NamePT ActionActionRatingTargetDate
BairdAnnouncesInitiates Coverage OnStrong Buy$5.0005/14/19
*Last 90 days

OPEN RECOMMENDATIONS

Stocks
Service NameTrader NamePosition TypeTarget %Target PriceTarget Date Issue Date
Trading SystemsTrading SystemsSubscribe1,200.39 %Subscribe03/12/1903/12/18View


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $PIRS

RECENT SUCCESSFUL RECOMMENDATIONS

SymbolService NamePosition TypeIssuePrice Target PriceClose Date% Return Comments
PIRSOption RipperBuy Long$5.08$10.0007/24/1821.65 %CommentsView
PIRSTrading SystemsBuy Long$6.39$10.0001/08/1811.27 %CommentsView
PIRSTrading SystemsBuy Long$6.23$10.0001/08/1814.13 %CommentsView

TRENDING ARTICLES



Health Care Sector Update for 05/10/2019: JNJ, PFE, ABT, MRK, AMGN, GENE, PIRS, TGTX

05/10/19
Top Health Care StocksTop Health Care Stocks JNJ 0 3 JNJ 0 3 PFE 0 2 PFE 0 2 ABT 0 2 ABT 0 2 MRK 0 3 MRK 0 3 AMGN 0 6 AMGN 0 6 Health care stocks were mixed just ahead of the close of Friday s session including a 0 2 rise in the NYSE Health Care Index NYP Shares

Analysts Estimate Pieris Pharmaceuticals (PIRS) to Report a Decline in Earnings: What to Look Out for

05/02/19
The market expects Pieris Pharmaceuticals PIRS to deliver a year over year decline in earnings on higher revenues when i t report s results for the quarter ended March 2019 This widely known consensus outlook is important in assessing the company s earnings picture but a powerful factor